Table 4.

Primer sequences

Target gene	Accession number	Forward	Reverse
Murine
αSMA	NM_007392.3	5′‐CTGACAGAGGCACCACTGAA‐3′	5′‐CATCTCCAGAGTCCAGCACA‐3′
FN	NM_010233.2	5′‐AATGGAAAAGGGGAATGGAC‐3′	5′‐CTCGGTTGTCCTTCTTGCTC‐3′
EP2	NM_008964.4	5′‐ATGCTCCTGCTGCTTATCGT‐3′	5′‐AGGGCCTCTTAGGCTACTGC‐3′
COL1A1	NM_007742.4	5′‐CACCCTCAAGAGCCTGAGTC‐3′	5′‐ACTCTCCGCTCTTCCAGTCA‐3′
18S	NM_011296.2	5′‐GAAAATAGCCTTCGCCATCA‐3′	5′‐TCCCATCCTTCACATCCTTC‐3′
Human
EP2	NM_000956.3	5′‐CCACCTCATTCTCCTGGCTA‐3′	5′‐TTCCTTTCGGGAAGAGGTTT‐3′
αSMA	NM_001141945.2	5′‐ACCCACAATGTCCCCATCTA‐3′	5′‐GAAGGAATAGCCACGCTCAG‐3′
FN	NM_212482.2	5′‐CAGTGGGAGACCTCGAGAAG‐3′	5′‐GTCCCTCGGAACATCAGAAA‐3′
COL1A1	NM_000088.3	5′‐CCTGGATGCCATCAAAGTCT‐3′	5′‐AATCCATCGGTCATGCTCTC‐3′
RPL22	NM_000983.3	5′‐TCGCTCACCTCCCTTTCTAA‐3′	5′‐TCACGGTGATCTTGCTCTTG‐3′
GAPDH	NM_002046.5	5′‐ACCAGGGCTGCTTTTAACTCT‐3′	5′‐GGTGCCATGGAATTTGCC‐3′
Canine
TGFβ	NM_001003309.1	5′‐AAGAAAAGTCCGCACAGCAT‐3′	5′‐GCTGCTCCGCTTTTAACTTG‐3′
GAPDH	NM_001003142.2	5′‐AACATCATCCCTGCTTCCAC‐3′	5′‐GGCAGGTCAGATCCACAACT‐3′